Virtual karyotype (English Wikipedia)

Analysis of information sources in references of the Wikipedia article "Virtual karyotype" in English language version.

refsWebsite

Global rank English rank

80nih.gov

4^th place

58doi.org

2^nd place

13semanticscholar.org

11^th place

8^th place

4harvard.edu

18^th place

17^th place

3handle.net

102^nd place

76^th place

1pnas.org

1,293^rd place

3,794^th place

1jco.org

low place

1AtlasGeneticsOncology.org

low place

1aacrjournals.org

8,869^th place

8,487^th place

1rug.nl

2,779^th place

1,997^th place

AtlasGeneticsOncology.org

van den Berg, E; Störkel, S (2003). "Kidney: Clear cell renal cell carcinoma". Atlas Genet Cytogenet Oncol Haematol. 7 (3): 424–431. Retrieved 14 December 2010.

aacrjournals.org

cancerres.aacrjournals.org

Ohgaki H, Eibl RH, Wiestler OD, Yasargil MG, Newcomb EW, Kleihues P (15 November 1991). "p53 mutations in nonastrocytic human brain tumors". Cancer Res. 51 (22): 6202–5. PMID 1933879.

doi.org

Shinawi M, Cheung SW (2008). "The array CGH and its clinical applications". Drug Discov Today. 13 (17–18): 760–70. doi:10.1016/j.drudis.2008.06.007. PMID 18617013.
Shaffer LG, Bejjani B (2006). "Medical applications of array CGH and the transformation of clinical cytogenetics". Cytogenet. Genome Res. 115 (3–4): 303–9. doi:10.1159/000095928. PMID 17124414. S2CID 31045279.
Edelmann L, Hirschhorn K (January 2009). "Clinical utility of array CGH for the detection of chromosomal imbalances associated with mental retardation and multiple congenital anomalies". Annals of the New York Academy of Sciences. 1151 (1): 157–66. Bibcode:2009NYASA1151..157E. doi:10.1111/j.1749-6632.2008.03610.x. PMID 19154522. S2CID 27612065.
Dutt A, Beroukhim R (January 2007). "Single nucleotide polymorphism array analysis of cancer". Current Opinion in Oncology. 19 (1): 43–9. doi:10.1097/CCO.0b013e328011a8c1. PMID 17133111. S2CID 25677498.
Hagenkord JM; Parwani AV; Lyons-Weiler MA; Alvarez K; Amato R; Gatalica Z; Gonzalez-Berjon JM; Peterson L; Dhir R; Monzon FA (November 2008). "Virtual karyotyping with SNP microarrays reduces uncertainty in the diagnosis of renal epithelial tumors". Diagn Pathol. 3 (1): 44. doi:10.1186/1746-1596-3-44. PMC 2588560. PMID 18990225.
Beaudet AL, Belmont J (2008). "Array-based DNA diagnostics: let the revolution begin". Annu Rev Med. 59 (1): 113–29. doi:10.1146/annurev.med.59.012907.101800. PMID 17961075.
Monzon FA; Hagenkord JM; Lyons-Weiler MA; Balani JP; Parwani AV; Sciulli CM; Li J; Chandran UR; Bastacky SI; Dhir R (May 2008). "Whole genome SNP arrays as a potential diagnostic tool for the detection of characteristic chromosomal aberrations in renal epithelial tumors". Mod Pathol. 21 (5): 599–608. doi:10.1038/modpathol.2008.20. PMID 18246049.
Leary RJ; Lin JC; Cummins J; Boca S; Wood LD; Parsons DW; Jones S; Sjöblom T; Park BH; Parsons R; Willis J; Dawson D; Willson JK; Nikolskaya T; Nikolsky Y; Kopelovich L; Papadopoulos N; Pennacchio LA; Wang TL; Markowitz SD; Parmigiani G; Kinzler KW; Vogelstein B; Velculescu VE (2008). "Integrated analysis of homozygous deletions, focal amplifications, and sequence alterations in breast and colorectal cancers". Proc Natl Acad Sci U S A. 105 (42): 16224–9. Bibcode:2008PNAS..10516224L. doi:10.1073/pnas.0808041105. PMC 2571022. PMID 18852474.
Lehmann S; Ogawa S; Raynaud SD; Sanada M; Nannya Y; Ticchioni M; Bastard C; Kawamata N; Koeffler HP (March 2008). "Molecular allelokaryotyping of early-stage, untreated chronic lymphocytic leukemia". Cancer. 112 (6): 1296–305. doi:10.1002/cncr.23270. PMID 18246537.
Vermeesch JR; Fiegler H; de Leeuw N; Szuhai K; Schoumans J; Ciccone R; Speleman F; Rauch A; Clayton-Smith J; Van Ravenswaaij C; Sanlaville D; Patsalis PC; Firth H; Devriendt K; Zuffardi O (November 2007). "Guidelines for molecular karyotyping in constitutional genetic diagnosis". Eur J Hum Genet. 15 (11): 1105–14. doi:10.1038/sj.ejhg.5201896. PMID 17637806.
Kulharya AS, Flannery DB, Norris K, Lovell C, Levy B, Velagaleti G (September 2008). "Fine mapping of breakpoints in two unrelated patients with rare overlapping interstitial deletions of 9q with mild dysmorphic features". American Journal of Medical Genetics. 146A (17): 2234–41. doi:10.1002/ajmg.a.32397. PMID 18666229. S2CID 25455126.
Nowakowska B; Stankiewicz P; Obersztyn E; Ou Z; Li J; Chinault AC; Smyk M; Borg K; Mazurczak T; Cheung SW; Bocian E (September 2008). "Application of metaphase HR-CGH and targeted Chromosomal Microarray Analyses to genomic characterization of 116 patients with mental retardation and dysmorphic features". American Journal of Medical Genetics. 146A (18): 2361–9. doi:10.1002/ajmg.a.32475. PMID 18698622. S2CID 30882747.
Probst FJ; Roeder ER; Enciso VB; Ou Z; Cooper ML; Eng P; Li J; Gu Y; Stratton RF; Chinault AC; Shaw CA; Sutton VR; Cheung SW; Nelson DL (June 2007). "Chromosomal microarray analysis (CMA) detects a large X chromosome deletion including FMR1, FMR2, and IDS in a female patient with mental retardation". American Journal of Medical Genetics. 143A (12): 1358–65. doi:10.1002/ajmg.a.31781. PMID 17506108. S2CID 22090841.
Hildebrandt, F; et al. (January 2009). "A systematic approach to mapping recessive disease genes in individuals from outbred populations". PLOS Genet. 5 (1): e1000353. doi:10.1371/journal.pgen.1000353. PMC 2621355. PMID 19165332.
McQuillan R; Leutenegger AL; Abdel-Rahman R; Franklin CS; Pericic M; Barac-Lauc L; Smolej-Narancic N; Janicijevic B; Polasek O; Tenesa A; Macleod AK; Farrington SM; Rudan P; Hayward C; Vitart V; Rudan I; Wild SH; Dunlop MG; Wright AF; Campbell H; Wilson JF (2008). "Runs of homozygosity in European populations". Am J Hum Genet. 83 (3): 359–72. doi:10.1016/j.ajhg.2008.08.007. PMC 2556426. PMID 18760389.
Gondek LP, Tiu R, O'Keefe CL, Sekeres MA, Theil KS, Maciejewski J (February 2008). "Chromosomal lesions and uniparental disomy detected by SNP arrays in MDS, MDS/MPD, and MDS-derived AML". Blood. 111 (3): 1534–42. doi:10.1182/blood-2007-05-092304. PMC 2214746. PMID 17954704.
Beroukhim R; Lin M; Park Y; Hao K; Zhao X; Garraway LA; Fox EA; Hochberg EP; Mellinghoff IK; Hofer MD; Descazeaud A; Rubin MA; Meyerson M; Wong WH; Sellers WR; Li C (May 2006). "Inferring loss-of-heterozygosity from unpaired tumors using high-density oligonucleotide SNP arrays". PLOS Comput. Biol. 2 (5): e41. Bibcode:2006PLSCB...2...41B. doi:10.1371/journal.pcbi.0020041. PMC 1458964. PMID 16699594.
Ishikawa S; Komura D; Tsuji S; Nishimura K; Yamamoto S; Panda B; Huang J; Fukayama M; Jones KW; Aburatani H (August 2005). "Allelic dosage analysis with genotyping microarrays". Biochem Biophys Res Commun. 333 (4): 1309–14. doi:10.1016/j.bbrc.2005.06.040. PMID 15982637.
Lo KC, Bailey D, Burkhardt T, Gardina P, Turpaz Y, Cowell J (March 2008). "Comprehensive analysis of loss of heterozygosity events in glioblastoma using the 100K SNP mapping arrays and comparison with copy number abnormalities defined by BAC array comparative genomic hybridization". Genes Chromosomes Cancer. 47 (3): 221–37. doi:10.1002/gcc.20524. PMID 18050302. S2CID 19480318.
Mao X, Young BD, Lu Y (June 2007). "The application of single nucleotide polymorphism microarrays in cancer research". Curr Genomics. 8 (4): 219–28. doi:10.2174/138920207781386924. PMC 2430687. PMID 18645599.
Janoueix-Lerosey I, Schleiermacher G, Michels E, et al. (March 2009). "Overall genomic pattern is a predictor of outcome in neuroblastoma". J. Clin. Oncol. 27 (7): 1026–33. doi:10.1200/JCO.2008.16.0630. PMID 19171713.
Michels E, Vandesompele J, Hoebeeck J, Menten B, De Preter K, Laureys G, Van Roy N, Speleman F (2006). "Genome wide measurement of DNA copy number changes in neuroblastoma: dissecting amplicons and mapping losses, gains and breakpoints". Cytogenet. Genome Res. 115 (3–4): 273–282. doi:10.1159/000095924. PMID 17124410. S2CID 14012430.
Messahel B; Williams R; Ridolfi A; A'hern R; Warren W; Tinworth L; Hobson R; Al-Saadi R; Whyman G; Brundler MA; Kelsey A; Sebire N; Jones C; Vujanic G; Pritchard-Jones K; Children's Cancer and Leukaemia Group (CCLG) (March 2009). "Children's Cancer and Leukaemia Group (CCLG). Allele loss at 16q defines poorer prognosis Wilms tumour irrespective of treatment approach in the UKW1-3 clinical trials: a Children's Cancer and Leukaemia Group (CCLG) Study". Eur J Cancer. 45 (5): 819–26. doi:10.1016/j.ejca.2009.01.005. PMID 19231157.
Grundy PE; Breslow NE; Li S; Perlman E; Beckwith JB; Ritchey ML; Shamberger RC; Haase GM; D'Angio GJ; Donaldson M; Coppes MJ; Malogolowkin M; Shearer P; Thomas PR; Macklis R; Tomlinson G; Huff V; Green DM; National Wilms Tumor Study Group (October 2005). "National Wilms Tumor Study Group. Loss of heterozygosity for chromosomes 1p and 16q is an adverse prognostic factor in favorable-histology Wilms tumor: a report from the National Wilms Tumor Study Group". J Clin Oncol. 23 (29): 7312–21. doi:10.1200/JCO.2005.01.2799. PMID 16129848.
Lyons-Weiler MA, Hagenkord JM, Sciulli CM, Dhir R, Monzon F (2008). "Optimization of the Affymetrix GeneChip Mapping 10K 2.0 Assay for Routine Clinical Use on Formalin Fixed Paraffin Embedded Tissues". Diag Mol Path. 17 (1): 3–13. doi:10.1097/PDM.0b013e31815aca30. PMID 18303412. S2CID 24420204.
Klatte T; Pantuck AJ; Said JW; Seligson DB; Rao NP; LaRochelle JC; Shuch B; Zisman A; Kabbinavar FF; Belldegrun AS (2009). "Cytogenetic and molecular tumor profiling for type 1 and type 2 papillary renal cell carcinoma". Clinical Cancer Research. 15 (4): 1162–9. doi:10.1158/1078-0432.CCR-08-1229. PMID 19228721.
Brunelli M; Eccher A; Gobbo S; Ficarra V; Novara G; Cossu-Rocca P; Bonetti F; Menestrina F; Cheng L; Eble JN; Martignoni G (2008). "Loss of chromosome 9p is an independent prognostic factor in patients with clear cell renal cell carcinoma". Modern Pathology. 21 (1): 1–6. doi:10.1038/modpathol.3800967. hdl:11380/1317439. PMID 17906617.
Klatte T; Rao PN; de Martino M; LaRochelle J; Shuch B; Zomorodian N; Said J; Kabbinavar FF; Belldegrun AS; Pantuck AJ (2009). "Cytogenetic profile predicts prognosis of patients with clear cell renal cell carcinoma". Journal of Clinical Oncology. 27 (5): 746–53. doi:10.1200/JCO.2007.15.8345. PMID 19124809.
Szponar A, Zubakov D, Pawlak J, Jauch A, Kovacs G (2009). "Three genetic developmental stages of papillary renal cell tumors: duplication of chromosome 1q marks fatal progression". International Journal of Cancer. 124 (9): 2071–6. doi:10.1002/ijc.24180. PMID 19123481.
Schwaenen C; Nessling M; Wessendorf S; Salvi T; Wrobel G; Radlwimmer B; Kestler HA; Haslinger C; Stilgenbauer S; Döhner H; Bentz M; Lichter P (2004). "Automated array-based genomic profiling in chronic lymphocytic leukemia: development of a clinical tool and discovery of recurrent genomic alterations". Proc Natl Acad Sci U S A. 101 (4): 1039–44. Bibcode:2004PNAS..101.1039S. doi:10.1073/pnas.0304717101. PMC 327147. PMID 14730057.
Pfeifer D; Pantic M; Skatulla I; Rawluk J; Kreutz C; Martens UM; Fisch P; Timmer J; Veelken H (February 2007). "Genome-wide analysis of DNA copy number changes and LOH in CLL using high-density SNP arrays". Blood. 109 (3): 1202–10. doi:10.1182/blood-2006-07-034256. PMID 17053054.
Gunn SR; Mohammed MS; Gorre ME; Cotter PD; Kim J; Bahler DW; Preobrazhensky SN; Higgins RA; Bolla AR; Ismail SH; de Jong D; Eldering E; van Oers MH; Mellink CH; Keating MJ; Schlette EJ; Abruzzo LV; Robetorye RS (September 2008). "Whole-genome scanning by array comparative genomic hybridization as a clinical tool for risk assessment in chronic lymphocytic leukemia". The Journal of Molecular Diagnostics. 10 (5): 442–451. doi:10.2353/jmoldx.2008.080033. PMC 2518739. PMID 18687794.
Sargent R; Jones D; Abruzzo LV; Yao H; Bonderover J; Cisneros M; Wierda WG; Keating MJ; Luthra R (January 2009). "Customized oligonucleotide array-based comparative genomic hybridization as a clinical assay for genomic profiling of chronic lymphocytic leukemia". J Mol Diagn. 11 (1): 25–34. doi:10.2353/jmoldx.2009.080037. PMC 2607562. PMID 19074592.
Hagenkord JM, Monzon FA, Kash SF, Lilleberg S, Xie Q, Kant JA (2010). "Array-based karyotyping for prognostic assessment in chronic lymphocytic leukemia: performance comparison of affymetrix 10K2.0, 250K Nsp, and SNP6.0 arrays". J Mol Diagn. 12 (2): 184–96. doi:10.2353/jmoldx.2010.090118. PMC 2871725. PMID 20075210.
Dohner H, Stilgenbauer S, Benner A, et al. (2000). "Genomic aberrations and survival in chronic lymphocytic leukemia". NEJM. 343 (26): 1910–6. doi:10.1056/NEJM200012283432602. PMID 11136261.
Hervé Avet-Loiseau; Cheng Li; Florence Magrangeas; Wilfried Gouraud; Catherine Charbonnel; Jean-Luc Harousseau; Michel Attal; Gerald Marit; Claire Mathiot; Thierry Facon; Philippe Moreau; Kenneth C. Anderson; Loïc Campion; Nikhil C. Munshi; Stéphane Minvielle (September 2009). "Prognostic significance of copy-number alterations in multiple myeloma". Journal of Clinical Oncology. 27 (27): 4585–90. doi:10.1200/JCO.2008.20.6136. PMC 2754906. PMID 19687334.
Pfister S; Remke M; Benner A; Mendrzyk F; Toedt G; Felsberg J; Wittmann A; Devens F; Gerber NU; Joos S; Kulozik A; Reifenberger G; Rutkowski S; Wiestler OD; Radlwimmer B; Scheurlen W; Lichter P; Korshunov A (April 2009). "Outcome Prediction in Pediatric Medulloblastoma based on DNA Copy Number Aberrations of Chromosomes 6q and 17q and the MYC and MYCN Loci". J Clin Oncol. 27 (10): 1627–1636. doi:10.1200/JCO.2008.17.9432. PMID 19255330.
Barbashina V, Salazar P, Holland EC, Rosenblum MK, Ladanyi M (1 February 2005). "Allelic losses at 1p36 and 19q13 in gliomas: correlation with histologic classification, definition of a 150-kb minimal deleted region on 1p36, and evaluation of CAMTA1 as a candidate tumor suppressor gene". Clin. Cancer Res. 11 (3): 1119–28. doi:10.1158/1078-0432.1119.11.3. PMID 15709179.
Laigle-Donadey F, Benouaich-Amiel A, Hoang-Xuan K, Sanson M (2005). "[Molecular biology of oligodendroglial tumors]". Neuro-Chirurgie (in French). 51 (3–4 Pt 2): 260–8. doi:10.1016/s0028-3770(05)83487-3. PMID 16292170.
Walker C, Haylock B, Husband D, et al. (2006). "Clinical use of genotype to predict chemosensitivity in oligodendroglial tumors". Neurology. 66 (11): 1661–7. doi:10.1212/01.wnl.0000218270.12495.9a. PMID 16769937. S2CID 39812093.
Jenkins RB, Blair H, Ballman KV, et al. (October 2006). "A t(1;19)(q10;p10) mediates the combined deletions of 1p and 19q and predicts a better prognosis of patients with oligodendroglioma". Cancer Res. 66 (20): 9852–61. doi:10.1158/0008-5472.CAN-06-1796. PMID 17047046.
Ducray F, Idbaih A, de Reyniès A, et al. (2008). "Anaplastic oligodendrogliomas with 1p19q codeletion have a proneural gene expression profile". Mol. Cancer. 7 (1): 41. doi:10.1186/1476-4598-7-41. PMC 2415112. PMID 18492260.
Dong Yin; Seishi Ogawa; Norihiko Kawamata; Patrizia Tunici; Gaetano Finocchiaro; Marica Eoli; Christian Ruckert; Thien Huynh; Gentao Liu; Motohiro Kato; Masashi Sanada; Anna Jauch; Martin Dugas; Keith L. Black; H. Phillip Koeffler (May 2009). "High-Resolution Genomic Copy Number Profiling of Glioblastoma Multiforme by Single Nucleotide Polymorphism DNA Microarray". Mol Cancer Res. 7 (5): 665–77. doi:10.1158/1541-7786.MCR-08-0270. PMID 19435819.
Moorman A, Harrison C, Buck G, Richards S, Secker-Walker L, Martineau M, Vance G, Cherry A, Higgins R, Fielding A, Foroni L, Paietta E, Tallman M, Litzow M, Wiernik P, Rowe J, Goldstone A, Dewald G (2007). "Karyotype is an independent prognostic factor in adult acute lymphoblastic leukemia (ALL): analysis of cytogenetic data from patients treated on the Medical Research Council (MRC) UKALLXII/Eastern Cooperative Oncology Group (ECOG) 2993 trial". Blood. 109 (8): 3189–97. doi:10.1182/blood-2006-10-051912. PMID 17170120. S2CID 1038016.
Kawamata N; Ogawa S; Zimmermann M; Kato M; Sanada M; Hemminki K; Yamatomo G; Nannya Y; Koehler R; Flohr T; Miller CW; Harbott J; Ludwig WD; Stanulla M; Schrappe M; Bartram CR; Koeffler HP (January 2008). "Molecular allelokaryotyping of pediatric acute lymphoblastic leukemias by high-resolution single nucleotide polymorphism oligonucleotide genomic microarray". Blood. 111 (2): 776–84. doi:10.1182/blood-2007-05-088310. PMC 2200831. PMID 17890455.
Bungaro S; Dell'Orto MC; Zangrando A; Basso D; Gorletta T; Lo Nigro L; Leszl A; Young BD; Basso G; Bicciato S; Biondi A; te Kronnie G; Cazzaniga G (January 2009). "Integration of genomic and gene expression data of childhood ALL without known aberrations identifies subgroups with specific genetic hallmarks". Genes Chromosomes Cancer. 48 (1): 22–38. doi:10.1002/gcc.20616. hdl:11380/612653. PMID 18803328.
Sulong S; Moorman AV; Irving JA; Strefford JC; Konn ZJ; Case MC; Minto L; Barber KE; Parker H; Wright SL; Stewart AR; Bailey S; Bown NP; Hall AG; Harrison CJ (January 2009). "A comprehensive analysis of the CDKN2A gene in childhood acute lymphoblastic leukemia reveals genomic deletion, copy number neutral loss of heterozygosity, and association with specific cytogenetic subgroups". Blood. 113 (1): 100–7. doi:10.1182/blood-2008-07-166801. PMID 18838613. S2CID 206872587.
Den Boer ML, van Slegtenhorst M, De Menezes RX, et al. (January 2009). "A subtype of childhood acute lymphoblastic leukaemia with poor treatment outcome: a genome-wide classification study". Lancet Oncol. 10 (2): 125–34. doi:10.1016/S1470-2045(08)70339-5. PMC 2707020. PMID 19138562.
Hasse D (2008). "Cytogenetic features in myelodysplastic syndromes". Ann Hematol. 87 (7): 515–526. doi:10.1007/s00277-008-0483-y. PMC 2413090. PMID 18414863.
Makishima H; Rataul M; Gondek LP; Huh J; Cook JR; Theil KS; Sekeres MA; Kuczkowski E; O'Keefe C; Maciejewski JP (2010). "FISH and SNP-A karyotyping in myelodysplastic syndromes: Improving cytogenetic detection of del(5q), monosomy 7, del(7q), trisomy 8, and del(20q)". Leuk Res. 34 (4): 447–453. doi:10.1016/j.leukres.2009.08.023. PMC 2826525. PMID 19758696.
Gondek LP, Tiu R, O'Keefe CL, Sekeres MA, Theil KS, MacIejewski JP (2008). "Chromosomal lesions and uniparental disomy detected by SNP arrays in MDS, MDS/MPD, and MDS-derived AML". Blood. 111 (3): 1534–42. doi:10.1182/blood-2007-05-092304. PMC 2214746. PMID 17954704.
Thoennissen NH; Krug UO; Lee DH; Kawamata N; Iwanski GB; Lasho T; Weiss T; Nowak D; Koren-Michowitz M; Kato M; Sanada M; Shih LY; Nagler A; Raynaud SD; Müller-Tidow C; Mesa R; Haferlach T; Gilliland DG; Tefferi A; Ogawa S; Koeffler HP (April 2010). "Prevalence and prognostic impact of allelic imbalances associated with leukemic transformation of Philadelphia chromosome-negative myeloproliferative neoplasms". Blood. 115 (14): 2882–2890. doi:10.1182/blood-2009-07-235119. PMC 2854432. PMID 20068225.
Jackson EM; Sievert AJ; Gai X; Hakonarson H; Judkins AR; Tooke L; Perin JC; Xie H; Shaikh TH; Biegel JA (2009). "Genomic analysis using high density single nucleotide polymorphism-based oligonucleotide arrays and multiplex ligation-dependent probe amplification provides comprehensive analysis of INI1/SMARCB1 in Malignant Rhabdoid Tumors". Clin Cancer Res. 15 (6): 1923–1930. doi:10.1158/1078-0432.CCR-08-2091. PMC 2668138. PMID 19276269.
Prescher G, Bornfeld N, Hirche H, Horsthemke B, Jöckel KH, Becher R (1996). "Prognostic implications of monosomy 3 in uveal melanoma". Lancet. 347 (9010): 1222–1225. doi:10.1016/S0140-6736(96)90736-9. PMID 8622452. S2CID 44328116.
Damato BE, Dopierala J, Klaasen A, van Dijk M, Sibbring J, Coupland S (2009). "Multiplex Ligation-Dependent Probe Amplification of Uveal Melanoma: Correlation with Metastatic Death" (PDF). Invest Ophthalmol Vis Sci. 50 (7): 3048–55. doi:10.1167/iovs.08-3165. hdl:11370/b69b62d5-b7c2-4afb-9fb2-60c6f71d4906. PMID 19182252.
White VA, McNeil BK, Horsman DE (1998). "Acquired homozygosity (isodisomy) of chromosome 3 in uveal melanoma". Cancer Genet Cytogenet. 102 (1): 40–45. doi:10.1016/S0165-4608(97)00290-2. PMID 9530338.
Onken MD, Worley LA, Person E, Char DH, Bowcock AM, Harbour JW (2007). "Loss of heterozygosity of chromosome 3 detected with single nucleotide polymorphisms is superior to monosomy 3 for predicting metastasis in uveal melanoma". Clin Cancer Res. 13 (10): 2923–2937. doi:10.1158/1078-0432.CCR-06-2383. PMID 17504992.
Yamamoto G; Nannya Y; Kato M; Sanada M; Levine RL; Kawamata N; Hangaishi A; Kurokawa M; Chiba S; Gilliland DG; Koeffler HP; Ogawa S (July 2007). "Highly sensitive method for genomewide detection of allelic composition in nonpaired, primary tumor specimens by use of affymetrix single-nucleotide-polymorphism genotyping microarrays". Am J Hum Genet. 81 (1): 114–26. doi:10.1086/518809. PMC 1950910. PMID 17564968.

handle.net

hdl.handle.net

Brunelli M; Eccher A; Gobbo S; Ficarra V; Novara G; Cossu-Rocca P; Bonetti F; Menestrina F; Cheng L; Eble JN; Martignoni G (2008). "Loss of chromosome 9p is an independent prognostic factor in patients with clear cell renal cell carcinoma". Modern Pathology. 21 (1): 1–6. doi:10.1038/modpathol.3800967. hdl:11380/1317439. PMID 17906617.
Bungaro S; Dell'Orto MC; Zangrando A; Basso D; Gorletta T; Lo Nigro L; Leszl A; Young BD; Basso G; Bicciato S; Biondi A; te Kronnie G; Cazzaniga G (January 2009). "Integration of genomic and gene expression data of childhood ALL without known aberrations identifies subgroups with specific genetic hallmarks". Genes Chromosomes Cancer. 48 (1): 22–38. doi:10.1002/gcc.20616. hdl:11380/612653. PMID 18803328.
Damato BE, Dopierala J, Klaasen A, van Dijk M, Sibbring J, Coupland S (2009). "Multiplex Ligation-Dependent Probe Amplification of Uveal Melanoma: Correlation with Metastatic Death" (PDF). Invest Ophthalmol Vis Sci. 50 (7): 3048–55. doi:10.1167/iovs.08-3165. hdl:11370/b69b62d5-b7c2-4afb-9fb2-60c6f71d4906. PMID 19182252.

harvard.edu

ui.adsabs.harvard.edu

Edelmann L, Hirschhorn K (January 2009). "Clinical utility of array CGH for the detection of chromosomal imbalances associated with mental retardation and multiple congenital anomalies". Annals of the New York Academy of Sciences. 1151 (1): 157–66. Bibcode:2009NYASA1151..157E. doi:10.1111/j.1749-6632.2008.03610.x. PMID 19154522. S2CID 27612065.
Leary RJ; Lin JC; Cummins J; Boca S; Wood LD; Parsons DW; Jones S; Sjöblom T; Park BH; Parsons R; Willis J; Dawson D; Willson JK; Nikolskaya T; Nikolsky Y; Kopelovich L; Papadopoulos N; Pennacchio LA; Wang TL; Markowitz SD; Parmigiani G; Kinzler KW; Vogelstein B; Velculescu VE (2008). "Integrated analysis of homozygous deletions, focal amplifications, and sequence alterations in breast and colorectal cancers". Proc Natl Acad Sci U S A. 105 (42): 16224–9. Bibcode:2008PNAS..10516224L. doi:10.1073/pnas.0808041105. PMC 2571022. PMID 18852474.
Beroukhim R; Lin M; Park Y; Hao K; Zhao X; Garraway LA; Fox EA; Hochberg EP; Mellinghoff IK; Hofer MD; Descazeaud A; Rubin MA; Meyerson M; Wong WH; Sellers WR; Li C (May 2006). "Inferring loss-of-heterozygosity from unpaired tumors using high-density oligonucleotide SNP arrays". PLOS Comput. Biol. 2 (5): e41. Bibcode:2006PLSCB...2...41B. doi:10.1371/journal.pcbi.0020041. PMC 1458964. PMID 16699594.
Schwaenen C; Nessling M; Wessendorf S; Salvi T; Wrobel G; Radlwimmer B; Kestler HA; Haslinger C; Stilgenbauer S; Döhner H; Bentz M; Lichter P (2004). "Automated array-based genomic profiling in chronic lymphocytic leukemia: development of a clinical tool and discovery of recurrent genomic alterations". Proc Natl Acad Sci U S A. 101 (4): 1039–44. Bibcode:2004PNAS..101.1039S. doi:10.1073/pnas.0304717101. PMC 327147. PMID 14730057.

jco.org

Janoueix-Lerosey I, Schleiermacher G, Michels E, et al. (March 2009). "Overall genomic pattern is a predictor of outcome in neuroblastoma". J. Clin. Oncol. 27 (7): 1026–33. doi:10.1200/JCO.2008.16.0630. PMID 19171713.

nih.gov

pubmed.ncbi.nlm.nih.gov

Shinawi M, Cheung SW (2008). "The array CGH and its clinical applications". Drug Discov Today. 13 (17–18): 760–70. doi:10.1016/j.drudis.2008.06.007. PMID 18617013.
Shaffer LG, Bejjani B (2006). "Medical applications of array CGH and the transformation of clinical cytogenetics". Cytogenet. Genome Res. 115 (3–4): 303–9. doi:10.1159/000095928. PMID 17124414. S2CID 31045279.
Edelmann L, Hirschhorn K (January 2009). "Clinical utility of array CGH for the detection of chromosomal imbalances associated with mental retardation and multiple congenital anomalies". Annals of the New York Academy of Sciences. 1151 (1): 157–66. Bibcode:2009NYASA1151..157E. doi:10.1111/j.1749-6632.2008.03610.x. PMID 19154522. S2CID 27612065.
Dutt A, Beroukhim R (January 2007). "Single nucleotide polymorphism array analysis of cancer". Current Opinion in Oncology. 19 (1): 43–9. doi:10.1097/CCO.0b013e328011a8c1. PMID 17133111. S2CID 25677498.
Hagenkord JM; Parwani AV; Lyons-Weiler MA; Alvarez K; Amato R; Gatalica Z; Gonzalez-Berjon JM; Peterson L; Dhir R; Monzon FA (November 2008). "Virtual karyotyping with SNP microarrays reduces uncertainty in the diagnosis of renal epithelial tumors". Diagn Pathol. 3 (1): 44. doi:10.1186/1746-1596-3-44. PMC 2588560. PMID 18990225.
Beaudet AL, Belmont J (2008). "Array-based DNA diagnostics: let the revolution begin". Annu Rev Med. 59 (1): 113–29. doi:10.1146/annurev.med.59.012907.101800. PMID 17961075.
Monzon FA; Hagenkord JM; Lyons-Weiler MA; Balani JP; Parwani AV; Sciulli CM; Li J; Chandran UR; Bastacky SI; Dhir R (May 2008). "Whole genome SNP arrays as a potential diagnostic tool for the detection of characteristic chromosomal aberrations in renal epithelial tumors". Mod Pathol. 21 (5): 599–608. doi:10.1038/modpathol.2008.20. PMID 18246049.
Leary RJ; Lin JC; Cummins J; Boca S; Wood LD; Parsons DW; Jones S; Sjöblom T; Park BH; Parsons R; Willis J; Dawson D; Willson JK; Nikolskaya T; Nikolsky Y; Kopelovich L; Papadopoulos N; Pennacchio LA; Wang TL; Markowitz SD; Parmigiani G; Kinzler KW; Vogelstein B; Velculescu VE (2008). "Integrated analysis of homozygous deletions, focal amplifications, and sequence alterations in breast and colorectal cancers". Proc Natl Acad Sci U S A. 105 (42): 16224–9. Bibcode:2008PNAS..10516224L. doi:10.1073/pnas.0808041105. PMC 2571022. PMID 18852474.
Lehmann S; Ogawa S; Raynaud SD; Sanada M; Nannya Y; Ticchioni M; Bastard C; Kawamata N; Koeffler HP (March 2008). "Molecular allelokaryotyping of early-stage, untreated chronic lymphocytic leukemia". Cancer. 112 (6): 1296–305. doi:10.1002/cncr.23270. PMID 18246537.
Vermeesch JR; Fiegler H; de Leeuw N; Szuhai K; Schoumans J; Ciccone R; Speleman F; Rauch A; Clayton-Smith J; Van Ravenswaaij C; Sanlaville D; Patsalis PC; Firth H; Devriendt K; Zuffardi O (November 2007). "Guidelines for molecular karyotyping in constitutional genetic diagnosis". Eur J Hum Genet. 15 (11): 1105–14. doi:10.1038/sj.ejhg.5201896. PMID 17637806.
Kulharya AS, Flannery DB, Norris K, Lovell C, Levy B, Velagaleti G (September 2008). "Fine mapping of breakpoints in two unrelated patients with rare overlapping interstitial deletions of 9q with mild dysmorphic features". American Journal of Medical Genetics. 146A (17): 2234–41. doi:10.1002/ajmg.a.32397. PMID 18666229. S2CID 25455126.
Nowakowska B; Stankiewicz P; Obersztyn E; Ou Z; Li J; Chinault AC; Smyk M; Borg K; Mazurczak T; Cheung SW; Bocian E (September 2008). "Application of metaphase HR-CGH and targeted Chromosomal Microarray Analyses to genomic characterization of 116 patients with mental retardation and dysmorphic features". American Journal of Medical Genetics. 146A (18): 2361–9. doi:10.1002/ajmg.a.32475. PMID 18698622. S2CID 30882747.
Probst FJ; Roeder ER; Enciso VB; Ou Z; Cooper ML; Eng P; Li J; Gu Y; Stratton RF; Chinault AC; Shaw CA; Sutton VR; Cheung SW; Nelson DL (June 2007). "Chromosomal microarray analysis (CMA) detects a large X chromosome deletion including FMR1, FMR2, and IDS in a female patient with mental retardation". American Journal of Medical Genetics. 143A (12): 1358–65. doi:10.1002/ajmg.a.31781. PMID 17506108. S2CID 22090841.
Hildebrandt, F; et al. (January 2009). "A systematic approach to mapping recessive disease genes in individuals from outbred populations". PLOS Genet. 5 (1): e1000353. doi:10.1371/journal.pgen.1000353. PMC 2621355. PMID 19165332.
McQuillan R; Leutenegger AL; Abdel-Rahman R; Franklin CS; Pericic M; Barac-Lauc L; Smolej-Narancic N; Janicijevic B; Polasek O; Tenesa A; Macleod AK; Farrington SM; Rudan P; Hayward C; Vitart V; Rudan I; Wild SH; Dunlop MG; Wright AF; Campbell H; Wilson JF (2008). "Runs of homozygosity in European populations". Am J Hum Genet. 83 (3): 359–72. doi:10.1016/j.ajhg.2008.08.007. PMC 2556426. PMID 18760389.
Gondek LP, Tiu R, O'Keefe CL, Sekeres MA, Theil KS, Maciejewski J (February 2008). "Chromosomal lesions and uniparental disomy detected by SNP arrays in MDS, MDS/MPD, and MDS-derived AML". Blood. 111 (3): 1534–42. doi:10.1182/blood-2007-05-092304. PMC 2214746. PMID 17954704.
Beroukhim R; Lin M; Park Y; Hao K; Zhao X; Garraway LA; Fox EA; Hochberg EP; Mellinghoff IK; Hofer MD; Descazeaud A; Rubin MA; Meyerson M; Wong WH; Sellers WR; Li C (May 2006). "Inferring loss-of-heterozygosity from unpaired tumors using high-density oligonucleotide SNP arrays". PLOS Comput. Biol. 2 (5): e41. Bibcode:2006PLSCB...2...41B. doi:10.1371/journal.pcbi.0020041. PMC 1458964. PMID 16699594.
Ishikawa S; Komura D; Tsuji S; Nishimura K; Yamamoto S; Panda B; Huang J; Fukayama M; Jones KW; Aburatani H (August 2005). "Allelic dosage analysis with genotyping microarrays". Biochem Biophys Res Commun. 333 (4): 1309–14. doi:10.1016/j.bbrc.2005.06.040. PMID 15982637.
Lo KC, Bailey D, Burkhardt T, Gardina P, Turpaz Y, Cowell J (March 2008). "Comprehensive analysis of loss of heterozygosity events in glioblastoma using the 100K SNP mapping arrays and comparison with copy number abnormalities defined by BAC array comparative genomic hybridization". Genes Chromosomes Cancer. 47 (3): 221–37. doi:10.1002/gcc.20524. PMID 18050302. S2CID 19480318.
Mao X, Young BD, Lu Y (June 2007). "The application of single nucleotide polymorphism microarrays in cancer research". Curr Genomics. 8 (4): 219–28. doi:10.2174/138920207781386924. PMC 2430687. PMID 18645599.
Janoueix-Lerosey I, Schleiermacher G, Michels E, et al. (March 2009). "Overall genomic pattern is a predictor of outcome in neuroblastoma". J. Clin. Oncol. 27 (7): 1026–33. doi:10.1200/JCO.2008.16.0630. PMID 19171713.
Michels E, Vandesompele J, Hoebeeck J, Menten B, De Preter K, Laureys G, Van Roy N, Speleman F (2006). "Genome wide measurement of DNA copy number changes in neuroblastoma: dissecting amplicons and mapping losses, gains and breakpoints". Cytogenet. Genome Res. 115 (3–4): 273–282. doi:10.1159/000095924. PMID 17124410. S2CID 14012430.
Messahel B; Williams R; Ridolfi A; A'hern R; Warren W; Tinworth L; Hobson R; Al-Saadi R; Whyman G; Brundler MA; Kelsey A; Sebire N; Jones C; Vujanic G; Pritchard-Jones K; Children's Cancer and Leukaemia Group (CCLG) (March 2009). "Children's Cancer and Leukaemia Group (CCLG). Allele loss at 16q defines poorer prognosis Wilms tumour irrespective of treatment approach in the UKW1-3 clinical trials: a Children's Cancer and Leukaemia Group (CCLG) Study". Eur J Cancer. 45 (5): 819–26. doi:10.1016/j.ejca.2009.01.005. PMID 19231157.
Grundy PE; Breslow NE; Li S; Perlman E; Beckwith JB; Ritchey ML; Shamberger RC; Haase GM; D'Angio GJ; Donaldson M; Coppes MJ; Malogolowkin M; Shearer P; Thomas PR; Macklis R; Tomlinson G; Huff V; Green DM; National Wilms Tumor Study Group (October 2005). "National Wilms Tumor Study Group. Loss of heterozygosity for chromosomes 1p and 16q is an adverse prognostic factor in favorable-histology Wilms tumor: a report from the National Wilms Tumor Study Group". J Clin Oncol. 23 (29): 7312–21. doi:10.1200/JCO.2005.01.2799. PMID 16129848.
Lyons-Weiler MA, Hagenkord JM, Sciulli CM, Dhir R, Monzon F (2008). "Optimization of the Affymetrix GeneChip Mapping 10K 2.0 Assay for Routine Clinical Use on Formalin Fixed Paraffin Embedded Tissues". Diag Mol Path. 17 (1): 3–13. doi:10.1097/PDM.0b013e31815aca30. PMID 18303412. S2CID 24420204.
Klatte T; Pantuck AJ; Said JW; Seligson DB; Rao NP; LaRochelle JC; Shuch B; Zisman A; Kabbinavar FF; Belldegrun AS (2009). "Cytogenetic and molecular tumor profiling for type 1 and type 2 papillary renal cell carcinoma". Clinical Cancer Research. 15 (4): 1162–9. doi:10.1158/1078-0432.CCR-08-1229. PMID 19228721.
Brunelli M; Eccher A; Gobbo S; Ficarra V; Novara G; Cossu-Rocca P; Bonetti F; Menestrina F; Cheng L; Eble JN; Martignoni G (2008). "Loss of chromosome 9p is an independent prognostic factor in patients with clear cell renal cell carcinoma". Modern Pathology. 21 (1): 1–6. doi:10.1038/modpathol.3800967. hdl:11380/1317439. PMID 17906617.
Klatte T; Rao PN; de Martino M; LaRochelle J; Shuch B; Zomorodian N; Said J; Kabbinavar FF; Belldegrun AS; Pantuck AJ (2009). "Cytogenetic profile predicts prognosis of patients with clear cell renal cell carcinoma". Journal of Clinical Oncology. 27 (5): 746–53. doi:10.1200/JCO.2007.15.8345. PMID 19124809.
Szponar A, Zubakov D, Pawlak J, Jauch A, Kovacs G (2009). "Three genetic developmental stages of papillary renal cell tumors: duplication of chromosome 1q marks fatal progression". International Journal of Cancer. 124 (9): 2071–6. doi:10.1002/ijc.24180. PMID 19123481.
Schwaenen C; Nessling M; Wessendorf S; Salvi T; Wrobel G; Radlwimmer B; Kestler HA; Haslinger C; Stilgenbauer S; Döhner H; Bentz M; Lichter P (2004). "Automated array-based genomic profiling in chronic lymphocytic leukemia: development of a clinical tool and discovery of recurrent genomic alterations". Proc Natl Acad Sci U S A. 101 (4): 1039–44. Bibcode:2004PNAS..101.1039S. doi:10.1073/pnas.0304717101. PMC 327147. PMID 14730057.
Pfeifer D; Pantic M; Skatulla I; Rawluk J; Kreutz C; Martens UM; Fisch P; Timmer J; Veelken H (February 2007). "Genome-wide analysis of DNA copy number changes and LOH in CLL using high-density SNP arrays". Blood. 109 (3): 1202–10. doi:10.1182/blood-2006-07-034256. PMID 17053054.
Gunn SR; Mohammed MS; Gorre ME; Cotter PD; Kim J; Bahler DW; Preobrazhensky SN; Higgins RA; Bolla AR; Ismail SH; de Jong D; Eldering E; van Oers MH; Mellink CH; Keating MJ; Schlette EJ; Abruzzo LV; Robetorye RS (September 2008). "Whole-genome scanning by array comparative genomic hybridization as a clinical tool for risk assessment in chronic lymphocytic leukemia". The Journal of Molecular Diagnostics. 10 (5): 442–451. doi:10.2353/jmoldx.2008.080033. PMC 2518739. PMID 18687794.
Sargent R; Jones D; Abruzzo LV; Yao H; Bonderover J; Cisneros M; Wierda WG; Keating MJ; Luthra R (January 2009). "Customized oligonucleotide array-based comparative genomic hybridization as a clinical assay for genomic profiling of chronic lymphocytic leukemia". J Mol Diagn. 11 (1): 25–34. doi:10.2353/jmoldx.2009.080037. PMC 2607562. PMID 19074592.
Hagenkord JM, Monzon FA, Kash SF, Lilleberg S, Xie Q, Kant JA (2010). "Array-based karyotyping for prognostic assessment in chronic lymphocytic leukemia: performance comparison of affymetrix 10K2.0, 250K Nsp, and SNP6.0 arrays". J Mol Diagn. 12 (2): 184–96. doi:10.2353/jmoldx.2010.090118. PMC 2871725. PMID 20075210.
Dohner H, Stilgenbauer S, Benner A, et al. (2000). "Genomic aberrations and survival in chronic lymphocytic leukemia". NEJM. 343 (26): 1910–6. doi:10.1056/NEJM200012283432602. PMID 11136261.
Hervé Avet-Loiseau; Cheng Li; Florence Magrangeas; Wilfried Gouraud; Catherine Charbonnel; Jean-Luc Harousseau; Michel Attal; Gerald Marit; Claire Mathiot; Thierry Facon; Philippe Moreau; Kenneth C. Anderson; Loïc Campion; Nikhil C. Munshi; Stéphane Minvielle (September 2009). "Prognostic significance of copy-number alterations in multiple myeloma". Journal of Clinical Oncology. 27 (27): 4585–90. doi:10.1200/JCO.2008.20.6136. PMC 2754906. PMID 19687334.
Pfister S; Remke M; Benner A; Mendrzyk F; Toedt G; Felsberg J; Wittmann A; Devens F; Gerber NU; Joos S; Kulozik A; Reifenberger G; Rutkowski S; Wiestler OD; Radlwimmer B; Scheurlen W; Lichter P; Korshunov A (April 2009). "Outcome Prediction in Pediatric Medulloblastoma based on DNA Copy Number Aberrations of Chromosomes 6q and 17q and the MYC and MYCN Loci". J Clin Oncol. 27 (10): 1627–1636. doi:10.1200/JCO.2008.17.9432. PMID 19255330.
Barbashina V, Salazar P, Holland EC, Rosenblum MK, Ladanyi M (1 February 2005). "Allelic losses at 1p36 and 19q13 in gliomas: correlation with histologic classification, definition of a 150-kb minimal deleted region on 1p36, and evaluation of CAMTA1 as a candidate tumor suppressor gene". Clin. Cancer Res. 11 (3): 1119–28. doi:10.1158/1078-0432.1119.11.3. PMID 15709179.
Laigle-Donadey F, Benouaich-Amiel A, Hoang-Xuan K, Sanson M (2005). "[Molecular biology of oligodendroglial tumors]". Neuro-Chirurgie (in French). 51 (3–4 Pt 2): 260–8. doi:10.1016/s0028-3770(05)83487-3. PMID 16292170.
Walker C, Haylock B, Husband D, et al. (2006). "Clinical use of genotype to predict chemosensitivity in oligodendroglial tumors". Neurology. 66 (11): 1661–7. doi:10.1212/01.wnl.0000218270.12495.9a. PMID 16769937. S2CID 39812093.
Jenkins RB, Blair H, Ballman KV, et al. (October 2006). "A t(1;19)(q10;p10) mediates the combined deletions of 1p and 19q and predicts a better prognosis of patients with oligodendroglioma". Cancer Res. 66 (20): 9852–61. doi:10.1158/0008-5472.CAN-06-1796. PMID 17047046.
Ohgaki H, Eibl RH, Wiestler OD, Yasargil MG, Newcomb EW, Kleihues P (15 November 1991). "p53 mutations in nonastrocytic human brain tumors". Cancer Res. 51 (22): 6202–5. PMID 1933879.
Ducray F, Idbaih A, de Reyniès A, et al. (2008). "Anaplastic oligodendrogliomas with 1p19q codeletion have a proneural gene expression profile". Mol. Cancer. 7 (1): 41. doi:10.1186/1476-4598-7-41. PMC 2415112. PMID 18492260.
Dong Yin; Seishi Ogawa; Norihiko Kawamata; Patrizia Tunici; Gaetano Finocchiaro; Marica Eoli; Christian Ruckert; Thien Huynh; Gentao Liu; Motohiro Kato; Masashi Sanada; Anna Jauch; Martin Dugas; Keith L. Black; H. Phillip Koeffler (May 2009). "High-Resolution Genomic Copy Number Profiling of Glioblastoma Multiforme by Single Nucleotide Polymorphism DNA Microarray". Mol Cancer Res. 7 (5): 665–77. doi:10.1158/1541-7786.MCR-08-0270. PMID 19435819.
Moorman A, Harrison C, Buck G, Richards S, Secker-Walker L, Martineau M, Vance G, Cherry A, Higgins R, Fielding A, Foroni L, Paietta E, Tallman M, Litzow M, Wiernik P, Rowe J, Goldstone A, Dewald G (2007). "Karyotype is an independent prognostic factor in adult acute lymphoblastic leukemia (ALL): analysis of cytogenetic data from patients treated on the Medical Research Council (MRC) UKALLXII/Eastern Cooperative Oncology Group (ECOG) 2993 trial". Blood. 109 (8): 3189–97. doi:10.1182/blood-2006-10-051912. PMID 17170120. S2CID 1038016.
Kawamata N; Ogawa S; Zimmermann M; Kato M; Sanada M; Hemminki K; Yamatomo G; Nannya Y; Koehler R; Flohr T; Miller CW; Harbott J; Ludwig WD; Stanulla M; Schrappe M; Bartram CR; Koeffler HP (January 2008). "Molecular allelokaryotyping of pediatric acute lymphoblastic leukemias by high-resolution single nucleotide polymorphism oligonucleotide genomic microarray". Blood. 111 (2): 776–84. doi:10.1182/blood-2007-05-088310. PMC 2200831. PMID 17890455.
Bungaro S; Dell'Orto MC; Zangrando A; Basso D; Gorletta T; Lo Nigro L; Leszl A; Young BD; Basso G; Bicciato S; Biondi A; te Kronnie G; Cazzaniga G (January 2009). "Integration of genomic and gene expression data of childhood ALL without known aberrations identifies subgroups with specific genetic hallmarks". Genes Chromosomes Cancer. 48 (1): 22–38. doi:10.1002/gcc.20616. hdl:11380/612653. PMID 18803328.
Sulong S; Moorman AV; Irving JA; Strefford JC; Konn ZJ; Case MC; Minto L; Barber KE; Parker H; Wright SL; Stewart AR; Bailey S; Bown NP; Hall AG; Harrison CJ (January 2009). "A comprehensive analysis of the CDKN2A gene in childhood acute lymphoblastic leukemia reveals genomic deletion, copy number neutral loss of heterozygosity, and association with specific cytogenetic subgroups". Blood. 113 (1): 100–7. doi:10.1182/blood-2008-07-166801. PMID 18838613. S2CID 206872587.
Den Boer ML, van Slegtenhorst M, De Menezes RX, et al. (January 2009). "A subtype of childhood acute lymphoblastic leukaemia with poor treatment outcome: a genome-wide classification study". Lancet Oncol. 10 (2): 125–34. doi:10.1016/S1470-2045(08)70339-5. PMC 2707020. PMID 19138562.
Hasse D (2008). "Cytogenetic features in myelodysplastic syndromes". Ann Hematol. 87 (7): 515–526. doi:10.1007/s00277-008-0483-y. PMC 2413090. PMID 18414863.
Makishima H; Rataul M; Gondek LP; Huh J; Cook JR; Theil KS; Sekeres MA; Kuczkowski E; O'Keefe C; Maciejewski JP (2010). "FISH and SNP-A karyotyping in myelodysplastic syndromes: Improving cytogenetic detection of del(5q), monosomy 7, del(7q), trisomy 8, and del(20q)". Leuk Res. 34 (4): 447–453. doi:10.1016/j.leukres.2009.08.023. PMC 2826525. PMID 19758696.
Gondek LP, Tiu R, O'Keefe CL, Sekeres MA, Theil KS, MacIejewski JP (2008). "Chromosomal lesions and uniparental disomy detected by SNP arrays in MDS, MDS/MPD, and MDS-derived AML". Blood. 111 (3): 1534–42. doi:10.1182/blood-2007-05-092304. PMC 2214746. PMID 17954704.
Thoennissen NH; Krug UO; Lee DH; Kawamata N; Iwanski GB; Lasho T; Weiss T; Nowak D; Koren-Michowitz M; Kato M; Sanada M; Shih LY; Nagler A; Raynaud SD; Müller-Tidow C; Mesa R; Haferlach T; Gilliland DG; Tefferi A; Ogawa S; Koeffler HP (April 2010). "Prevalence and prognostic impact of allelic imbalances associated with leukemic transformation of Philadelphia chromosome-negative myeloproliferative neoplasms". Blood. 115 (14): 2882–2890. doi:10.1182/blood-2009-07-235119. PMC 2854432. PMID 20068225.
Jackson EM; Sievert AJ; Gai X; Hakonarson H; Judkins AR; Tooke L; Perin JC; Xie H; Shaikh TH; Biegel JA (2009). "Genomic analysis using high density single nucleotide polymorphism-based oligonucleotide arrays and multiplex ligation-dependent probe amplification provides comprehensive analysis of INI1/SMARCB1 in Malignant Rhabdoid Tumors". Clin Cancer Res. 15 (6): 1923–1930. doi:10.1158/1078-0432.CCR-08-2091. PMC 2668138. PMID 19276269.
Prescher G, Bornfeld N, Hirche H, Horsthemke B, Jöckel KH, Becher R (1996). "Prognostic implications of monosomy 3 in uveal melanoma". Lancet. 347 (9010): 1222–1225. doi:10.1016/S0140-6736(96)90736-9. PMID 8622452. S2CID 44328116.
Damato BE, Dopierala J, Klaasen A, van Dijk M, Sibbring J, Coupland S (2009). "Multiplex Ligation-Dependent Probe Amplification of Uveal Melanoma: Correlation with Metastatic Death" (PDF). Invest Ophthalmol Vis Sci. 50 (7): 3048–55. doi:10.1167/iovs.08-3165. hdl:11370/b69b62d5-b7c2-4afb-9fb2-60c6f71d4906. PMID 19182252.
White VA, McNeil BK, Horsman DE (1998). "Acquired homozygosity (isodisomy) of chromosome 3 in uveal melanoma". Cancer Genet Cytogenet. 102 (1): 40–45. doi:10.1016/S0165-4608(97)00290-2. PMID 9530338.
Onken MD, Worley LA, Person E, Char DH, Bowcock AM, Harbour JW (2007). "Loss of heterozygosity of chromosome 3 detected with single nucleotide polymorphisms is superior to monosomy 3 for predicting metastasis in uveal melanoma". Clin Cancer Res. 13 (10): 2923–2937. doi:10.1158/1078-0432.CCR-06-2383. PMID 17504992.
Yamamoto G; Nannya Y; Kato M; Sanada M; Levine RL; Kawamata N; Hangaishi A; Kurokawa M; Chiba S; Gilliland DG; Koeffler HP; Ogawa S (July 2007). "Highly sensitive method for genomewide detection of allelic composition in nonpaired, primary tumor specimens by use of affymetrix single-nucleotide-polymorphism genotyping microarrays". Am J Hum Genet. 81 (1): 114–26. doi:10.1086/518809. PMC 1950910. PMID 17564968.

ncbi.nlm.nih.gov

Hagenkord JM; Parwani AV; Lyons-Weiler MA; Alvarez K; Amato R; Gatalica Z; Gonzalez-Berjon JM; Peterson L; Dhir R; Monzon FA (November 2008). "Virtual karyotyping with SNP microarrays reduces uncertainty in the diagnosis of renal epithelial tumors". Diagn Pathol. 3 (1): 44. doi:10.1186/1746-1596-3-44. PMC 2588560. PMID 18990225.
Leary RJ; Lin JC; Cummins J; Boca S; Wood LD; Parsons DW; Jones S; Sjöblom T; Park BH; Parsons R; Willis J; Dawson D; Willson JK; Nikolskaya T; Nikolsky Y; Kopelovich L; Papadopoulos N; Pennacchio LA; Wang TL; Markowitz SD; Parmigiani G; Kinzler KW; Vogelstein B; Velculescu VE (2008). "Integrated analysis of homozygous deletions, focal amplifications, and sequence alterations in breast and colorectal cancers". Proc Natl Acad Sci U S A. 105 (42): 16224–9. Bibcode:2008PNAS..10516224L. doi:10.1073/pnas.0808041105. PMC 2571022. PMID 18852474.
Hildebrandt, F; et al. (January 2009). "A systematic approach to mapping recessive disease genes in individuals from outbred populations". PLOS Genet. 5 (1): e1000353. doi:10.1371/journal.pgen.1000353. PMC 2621355. PMID 19165332.
McQuillan R; Leutenegger AL; Abdel-Rahman R; Franklin CS; Pericic M; Barac-Lauc L; Smolej-Narancic N; Janicijevic B; Polasek O; Tenesa A; Macleod AK; Farrington SM; Rudan P; Hayward C; Vitart V; Rudan I; Wild SH; Dunlop MG; Wright AF; Campbell H; Wilson JF (2008). "Runs of homozygosity in European populations". Am J Hum Genet. 83 (3): 359–72. doi:10.1016/j.ajhg.2008.08.007. PMC 2556426. PMID 18760389.
Gondek LP, Tiu R, O'Keefe CL, Sekeres MA, Theil KS, Maciejewski J (February 2008). "Chromosomal lesions and uniparental disomy detected by SNP arrays in MDS, MDS/MPD, and MDS-derived AML". Blood. 111 (3): 1534–42. doi:10.1182/blood-2007-05-092304. PMC 2214746. PMID 17954704.
Beroukhim R; Lin M; Park Y; Hao K; Zhao X; Garraway LA; Fox EA; Hochberg EP; Mellinghoff IK; Hofer MD; Descazeaud A; Rubin MA; Meyerson M; Wong WH; Sellers WR; Li C (May 2006). "Inferring loss-of-heterozygosity from unpaired tumors using high-density oligonucleotide SNP arrays". PLOS Comput. Biol. 2 (5): e41. Bibcode:2006PLSCB...2...41B. doi:10.1371/journal.pcbi.0020041. PMC 1458964. PMID 16699594.
Mao X, Young BD, Lu Y (June 2007). "The application of single nucleotide polymorphism microarrays in cancer research". Curr Genomics. 8 (4): 219–28. doi:10.2174/138920207781386924. PMC 2430687. PMID 18645599.
Schwaenen C; Nessling M; Wessendorf S; Salvi T; Wrobel G; Radlwimmer B; Kestler HA; Haslinger C; Stilgenbauer S; Döhner H; Bentz M; Lichter P (2004). "Automated array-based genomic profiling in chronic lymphocytic leukemia: development of a clinical tool and discovery of recurrent genomic alterations". Proc Natl Acad Sci U S A. 101 (4): 1039–44. Bibcode:2004PNAS..101.1039S. doi:10.1073/pnas.0304717101. PMC 327147. PMID 14730057.
Gunn SR; Mohammed MS; Gorre ME; Cotter PD; Kim J; Bahler DW; Preobrazhensky SN; Higgins RA; Bolla AR; Ismail SH; de Jong D; Eldering E; van Oers MH; Mellink CH; Keating MJ; Schlette EJ; Abruzzo LV; Robetorye RS (September 2008). "Whole-genome scanning by array comparative genomic hybridization as a clinical tool for risk assessment in chronic lymphocytic leukemia". The Journal of Molecular Diagnostics. 10 (5): 442–451. doi:10.2353/jmoldx.2008.080033. PMC 2518739. PMID 18687794.
Sargent R; Jones D; Abruzzo LV; Yao H; Bonderover J; Cisneros M; Wierda WG; Keating MJ; Luthra R (January 2009). "Customized oligonucleotide array-based comparative genomic hybridization as a clinical assay for genomic profiling of chronic lymphocytic leukemia". J Mol Diagn. 11 (1): 25–34. doi:10.2353/jmoldx.2009.080037. PMC 2607562. PMID 19074592.
Hagenkord JM, Monzon FA, Kash SF, Lilleberg S, Xie Q, Kant JA (2010). "Array-based karyotyping for prognostic assessment in chronic lymphocytic leukemia: performance comparison of affymetrix 10K2.0, 250K Nsp, and SNP6.0 arrays". J Mol Diagn. 12 (2): 184–96. doi:10.2353/jmoldx.2010.090118. PMC 2871725. PMID 20075210.
Hervé Avet-Loiseau; Cheng Li; Florence Magrangeas; Wilfried Gouraud; Catherine Charbonnel; Jean-Luc Harousseau; Michel Attal; Gerald Marit; Claire Mathiot; Thierry Facon; Philippe Moreau; Kenneth C. Anderson; Loïc Campion; Nikhil C. Munshi; Stéphane Minvielle (September 2009). "Prognostic significance of copy-number alterations in multiple myeloma". Journal of Clinical Oncology. 27 (27): 4585–90. doi:10.1200/JCO.2008.20.6136. PMC 2754906. PMID 19687334.
Ducray F, Idbaih A, de Reyniès A, et al. (2008). "Anaplastic oligodendrogliomas with 1p19q codeletion have a proneural gene expression profile". Mol. Cancer. 7 (1): 41. doi:10.1186/1476-4598-7-41. PMC 2415112. PMID 18492260.
Kawamata N; Ogawa S; Zimmermann M; Kato M; Sanada M; Hemminki K; Yamatomo G; Nannya Y; Koehler R; Flohr T; Miller CW; Harbott J; Ludwig WD; Stanulla M; Schrappe M; Bartram CR; Koeffler HP (January 2008). "Molecular allelokaryotyping of pediatric acute lymphoblastic leukemias by high-resolution single nucleotide polymorphism oligonucleotide genomic microarray". Blood. 111 (2): 776–84. doi:10.1182/blood-2007-05-088310. PMC 2200831. PMID 17890455.
Den Boer ML, van Slegtenhorst M, De Menezes RX, et al. (January 2009). "A subtype of childhood acute lymphoblastic leukaemia with poor treatment outcome: a genome-wide classification study". Lancet Oncol. 10 (2): 125–34. doi:10.1016/S1470-2045(08)70339-5. PMC 2707020. PMID 19138562.
Hasse D (2008). "Cytogenetic features in myelodysplastic syndromes". Ann Hematol. 87 (7): 515–526. doi:10.1007/s00277-008-0483-y. PMC 2413090. PMID 18414863.
Makishima H; Rataul M; Gondek LP; Huh J; Cook JR; Theil KS; Sekeres MA; Kuczkowski E; O'Keefe C; Maciejewski JP (2010). "FISH and SNP-A karyotyping in myelodysplastic syndromes: Improving cytogenetic detection of del(5q), monosomy 7, del(7q), trisomy 8, and del(20q)". Leuk Res. 34 (4): 447–453. doi:10.1016/j.leukres.2009.08.023. PMC 2826525. PMID 19758696.
Gondek LP, Tiu R, O'Keefe CL, Sekeres MA, Theil KS, MacIejewski JP (2008). "Chromosomal lesions and uniparental disomy detected by SNP arrays in MDS, MDS/MPD, and MDS-derived AML". Blood. 111 (3): 1534–42. doi:10.1182/blood-2007-05-092304. PMC 2214746. PMID 17954704.
Thoennissen NH; Krug UO; Lee DH; Kawamata N; Iwanski GB; Lasho T; Weiss T; Nowak D; Koren-Michowitz M; Kato M; Sanada M; Shih LY; Nagler A; Raynaud SD; Müller-Tidow C; Mesa R; Haferlach T; Gilliland DG; Tefferi A; Ogawa S; Koeffler HP (April 2010). "Prevalence and prognostic impact of allelic imbalances associated with leukemic transformation of Philadelphia chromosome-negative myeloproliferative neoplasms". Blood. 115 (14): 2882–2890. doi:10.1182/blood-2009-07-235119. PMC 2854432. PMID 20068225.
Jackson EM; Sievert AJ; Gai X; Hakonarson H; Judkins AR; Tooke L; Perin JC; Xie H; Shaikh TH; Biegel JA (2009). "Genomic analysis using high density single nucleotide polymorphism-based oligonucleotide arrays and multiplex ligation-dependent probe amplification provides comprehensive analysis of INI1/SMARCB1 in Malignant Rhabdoid Tumors". Clin Cancer Res. 15 (6): 1923–1930. doi:10.1158/1078-0432.CCR-08-2091. PMC 2668138. PMID 19276269.
Yamamoto G; Nannya Y; Kato M; Sanada M; Levine RL; Kawamata N; Hangaishi A; Kurokawa M; Chiba S; Gilliland DG; Koeffler HP; Ogawa S (July 2007). "Highly sensitive method for genomewide detection of allelic composition in nonpaired, primary tumor specimens by use of affymetrix single-nucleotide-polymorphism genotyping microarrays". Am J Hum Genet. 81 (1): 114–26. doi:10.1086/518809. PMC 1950910. PMID 17564968.

pnas.org

Digital karyotyping – Wang et al., 10.1073/pnas.202610899 – Proceedings of the National Academy of Sciences

rug.nl

Damato BE, Dopierala J, Klaasen A, van Dijk M, Sibbring J, Coupland S (2009). "Multiplex Ligation-Dependent Probe Amplification of Uveal Melanoma: Correlation with Metastatic Death" (PDF). Invest Ophthalmol Vis Sci. 50 (7): 3048–55. doi:10.1167/iovs.08-3165. hdl:11370/b69b62d5-b7c2-4afb-9fb2-60c6f71d4906. PMID 19182252.

semanticscholar.org

api.semanticscholar.org

Shaffer LG, Bejjani B (2006). "Medical applications of array CGH and the transformation of clinical cytogenetics". Cytogenet. Genome Res. 115 (3–4): 303–9. doi:10.1159/000095928. PMID 17124414. S2CID 31045279.
Edelmann L, Hirschhorn K (January 2009). "Clinical utility of array CGH for the detection of chromosomal imbalances associated with mental retardation and multiple congenital anomalies". Annals of the New York Academy of Sciences. 1151 (1): 157–66. Bibcode:2009NYASA1151..157E. doi:10.1111/j.1749-6632.2008.03610.x. PMID 19154522. S2CID 27612065.
Dutt A, Beroukhim R (January 2007). "Single nucleotide polymorphism array analysis of cancer". Current Opinion in Oncology. 19 (1): 43–9. doi:10.1097/CCO.0b013e328011a8c1. PMID 17133111. S2CID 25677498.
Kulharya AS, Flannery DB, Norris K, Lovell C, Levy B, Velagaleti G (September 2008). "Fine mapping of breakpoints in two unrelated patients with rare overlapping interstitial deletions of 9q with mild dysmorphic features". American Journal of Medical Genetics. 146A (17): 2234–41. doi:10.1002/ajmg.a.32397. PMID 18666229. S2CID 25455126.
Nowakowska B; Stankiewicz P; Obersztyn E; Ou Z; Li J; Chinault AC; Smyk M; Borg K; Mazurczak T; Cheung SW; Bocian E (September 2008). "Application of metaphase HR-CGH and targeted Chromosomal Microarray Analyses to genomic characterization of 116 patients with mental retardation and dysmorphic features". American Journal of Medical Genetics. 146A (18): 2361–9. doi:10.1002/ajmg.a.32475. PMID 18698622. S2CID 30882747.
Probst FJ; Roeder ER; Enciso VB; Ou Z; Cooper ML; Eng P; Li J; Gu Y; Stratton RF; Chinault AC; Shaw CA; Sutton VR; Cheung SW; Nelson DL (June 2007). "Chromosomal microarray analysis (CMA) detects a large X chromosome deletion including FMR1, FMR2, and IDS in a female patient with mental retardation". American Journal of Medical Genetics. 143A (12): 1358–65. doi:10.1002/ajmg.a.31781. PMID 17506108. S2CID 22090841.
Lo KC, Bailey D, Burkhardt T, Gardina P, Turpaz Y, Cowell J (March 2008). "Comprehensive analysis of loss of heterozygosity events in glioblastoma using the 100K SNP mapping arrays and comparison with copy number abnormalities defined by BAC array comparative genomic hybridization". Genes Chromosomes Cancer. 47 (3): 221–37. doi:10.1002/gcc.20524. PMID 18050302. S2CID 19480318.
Michels E, Vandesompele J, Hoebeeck J, Menten B, De Preter K, Laureys G, Van Roy N, Speleman F (2006). "Genome wide measurement of DNA copy number changes in neuroblastoma: dissecting amplicons and mapping losses, gains and breakpoints". Cytogenet. Genome Res. 115 (3–4): 273–282. doi:10.1159/000095924. PMID 17124410. S2CID 14012430.
Lyons-Weiler MA, Hagenkord JM, Sciulli CM, Dhir R, Monzon F (2008). "Optimization of the Affymetrix GeneChip Mapping 10K 2.0 Assay for Routine Clinical Use on Formalin Fixed Paraffin Embedded Tissues". Diag Mol Path. 17 (1): 3–13. doi:10.1097/PDM.0b013e31815aca30. PMID 18303412. S2CID 24420204.
Walker C, Haylock B, Husband D, et al. (2006). "Clinical use of genotype to predict chemosensitivity in oligodendroglial tumors". Neurology. 66 (11): 1661–7. doi:10.1212/01.wnl.0000218270.12495.9a. PMID 16769937. S2CID 39812093.
Moorman A, Harrison C, Buck G, Richards S, Secker-Walker L, Martineau M, Vance G, Cherry A, Higgins R, Fielding A, Foroni L, Paietta E, Tallman M, Litzow M, Wiernik P, Rowe J, Goldstone A, Dewald G (2007). "Karyotype is an independent prognostic factor in adult acute lymphoblastic leukemia (ALL): analysis of cytogenetic data from patients treated on the Medical Research Council (MRC) UKALLXII/Eastern Cooperative Oncology Group (ECOG) 2993 trial". Blood. 109 (8): 3189–97. doi:10.1182/blood-2006-10-051912. PMID 17170120. S2CID 1038016.
Sulong S; Moorman AV; Irving JA; Strefford JC; Konn ZJ; Case MC; Minto L; Barber KE; Parker H; Wright SL; Stewart AR; Bailey S; Bown NP; Hall AG; Harrison CJ (January 2009). "A comprehensive analysis of the CDKN2A gene in childhood acute lymphoblastic leukemia reveals genomic deletion, copy number neutral loss of heterozygosity, and association with specific cytogenetic subgroups". Blood. 113 (1): 100–7. doi:10.1182/blood-2008-07-166801. PMID 18838613. S2CID 206872587.
Prescher G, Bornfeld N, Hirche H, Horsthemke B, Jöckel KH, Becher R (1996). "Prognostic implications of monosomy 3 in uveal melanoma". Lancet. 347 (9010): 1222–1225. doi:10.1016/S0140-6736(96)90736-9. PMID 8622452. S2CID 44328116.